×
0.000310559006211118 0.000310559006211118 0.000310559006211118 0.000310559006211118 0.0170807453416148 0.0375776397515528 -0.00410248447204973 0.00559006211180123
Stockreport

Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018

Albireo Pharma, Inc (ALBO)  More Company Research Source: GlobeNewswire
Last albireo pharma, inc earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that new data from its completed Phase 2 trial of lead product candidate A4250 in children with cholestatic liver disease and pruritus will be presented during a poster session at the European Association for the Study of the Liver (EASL) The International Liver Congress 2018, being held April 11-15, 2018, at the Paris Convention Center in Paris. Details of the presentation are as follows: Title: Correlation of autotaxin levels, serum bile acids, and pruritus in a multiple-dose, open-label, multinational study of the ileal bile acid transport inhibitor A4250Abstract Number: 526Poster Session: Rare liver diseases (including paediatric and genetic)Date/Time: Saturday, April 14, 9 a.m. - 5 p.m. CESTLocation: Paris Convention Center, Pavilion 7, Hall 7.2Presenter: Dr. Emmanuel Gonzalès, Associate P [Read more]

IMPACT SNAPSHOT EVENT TIME: ALBO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ALBO alerts

from News Quantified
Opt-in for
ALBO alerts

from News Quantified